Cardiovascular and kidney health screening in AECOPD patients in Hong Kong

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective interventional study evaluates the burden of undiagnosed cardiovascular and renal disease in patients hospitalized for acute exacerbation of COPD at a Hong Kong public hospital. It introduces a COPD discharge care bundle that includes integrated cardiovascular and renal screening to identify undiscovered comorbidities. The study will describe how common these hidden conditions are, explore factors linked to future COPD flare-ups, and compare readmission rates to historical controls to inform integrated cardiopulmonary management. Eligible participants are adults aged 40 and older with a confirmed COPD diagnosis who are admitted for an exacerbation. The lead sponsor is The Chinese University of Hong Kong, with the Prince of Wales Hospital as the participating site.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥40 years
* Patients hospitalized due to COPD exacerbation.
* Patients diagnosed with COPD, a confirmed COPD diagnosis with a specific FEV1/FVC ratio (\<0.70)
* Able to provide informed consent

Exclusion Criteria:

* Pregnant subjects
* Inability to give informed consent
* Cancer patient who are on active chemotherapy or on palliative care

Where it's running

• Prince of Wales Hospital
  Shatin, Hong Kong, Hong Kong Recruiting

Study contacts

• Study coordinator: Fanny WS Ko, MD
• Email: fannyko@cuhk.edu.hk
• Phone: 85235053133

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer

  This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.

  Recruiting Phase 2 AeroRx Therapeutics Inc. · London and 1 other locations · NCT07896252

• Cognitive load and inhaler technique in COPD

  This study tests whether adding a short memory task while using an inhaler makes COPD patients more likely to misuse their inhaler.

  Recruiting Spitalul Clinic de Boli Infecțioase și Pneumoftiziologie Dr. Victor Babeș Timișoara · Timișoara, Timiș County · NCT07786220

• Balance training after pulmonary rehab for COPD to help steadiness and reduce falls

  A COPD-focused balance training program called Sport4Steadiness is being tested to see if people with COPD will accept it and if the study processes work well.

  Recruiting at 3 sites Teesside University · Middlesbrough and 2 other locations · NCT07750821

• Continuous vs High-Intensity Interval Exercise in COPD

  This study tests whether continuous versus high-intensity interval exercise affects cerebral oxygenation in people with COPD.

  Recruiting George Papanicolaou Hospital · Thessaloniki, Exohi · NCT07707271

• Biomarker clues for COPD, IPF, and lung cancer

  This study tests whether inflammation, immune, genetic, and epigenetic markers at enrollment can explain how COPD, IPF, or lung cancer present and behave, in order to see if these markers can predict outcomes over a year.

  Recruiting Fondazione Don Carlo Gnocchi ETS · Milan, Milan · NCT07707245

• HRS-9821 Inhalation Suspension for COPD: Safety and Dose Finding in Adults

  This study tests whether HRS-9821 inhalation can be safely taken and help people with moderate to severe COPD, and aims to find a reasonable dose.

  Recruiting Phase 2 Guangdong Hengrui Pharmaceutical Co., Ltd · Shanghai, Shanghai Municipality · NCT07640451

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.